Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

NCT00568984 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: repaglinide
DRUG: metformin
DRUG: glicazide

Sponsor

Novo Nordisk A/S